Asthma
A 2025 meta-analysis found cannabis use is linked to greater odds of asthma — and inhaling it irritates the airways. This is a caution, not a treatment.
Other Unsupported
What the research says
The headline is the opposite of a treatment effect. A 2025 systematic review and meta-analysis found cannabis use associated with significantly greater odds of asthma (pooled OR 1.31, 95% CI 1.19–1.44). And a 2022 meta-analysis of over 20,000 people found more frequent cannabis smoking linked to more wheezing, more coughing, and lower lung function — effects that track how much and how long people smoked.
There is no randomized trial showing cannabis helps asthma. The only plausible mechanism — CBD's anti-inflammatory action in cell and animal studies — has never been tested in humans with asthma, and oral CBD does not address the airway directly.
The honest caveats
If you have asthma, inhaled cannabis — smoked or vaped — is a genuine respiratory irritant and can trigger coughing, wheezing, and bronchospasm. This is a rare condition where the honest advice is close to a hard no for inhaled products, and any oral experiment should go through your pulmonologist. Asthma is well-managed with proven inhaled medications; nothing about cannabis changes that.
Compounds to explore
These are the compounds — terpenes and cannabinoids — that the research connects to this condition. They are starting points for reading a COA or choosing a product, not prescriptions. Each has its own guide with more detail.
Cannabinoid THC Smoking or vaping THC is the main concern — combustion and particulate irritate and can constrict airways. Cannabinoid CBD Anti-inflammatory in the lab, but no human study shows asthma benefit. Terpene beta-caryophyllene Anti-inflammatory terpene; only theoretical relevance to asthma. Terpene eucalyptol The strongest clinical track record of any terpene — used in licensed medicines for inflammatory airway conditions.